Corbus Pharmaceuticals
CRBP
CRBP
99 hedge funds and large institutions have $129M invested in Corbus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 26 closing their positions.
Holders
99
Holders Change
-8
Holders Change %
-7.48%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
34
Reduced
22
Closed
26
Calls
$6.57M
Puts
$776K
Net Calls
+$5.8M
Net Calls Change
+$1.77M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$4.56M |
| 2 |
O
2
OrbiMed
New York
|
$13.8M |
| 3 |
AC
3
Armistice Capital
New York
|
$2.78M |
| 4 |
ACM
4
Altium Capital Management
New York
|
$4.54M |
| 5 |
PM
5
Prosight Management
Dallas,
Texas
|
$3.19M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
126
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
CM
127
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
128
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|
|
GS
129
GTS Securities
New York
| – | – | – | – |
|
|
SCM
130
Silverarc Capital Management
Boston,
Massachusetts
| – | – | – | – |
|